The Effects of Brinolase (Fibrinolytic Enzyme from Aspergillus Oryzae) on Platelet Aggregation of Dog and Man

Summary

Inhibition of blood platelet aggregation by brinolase (fibrinolytic enzyme from Aspergillus oryzae) has been demonstrated with human platelets in vitro and with dog platelets in vivo and in vitro, using both ADP and collagen as aggregating stimuli. It is suggested that the optimal inhibitory effects of brinolase occur indirectly through the generation of plasma fibrinogen degradation products, without compromising platelet viability, rather than by direct proteolysis of platelet structures.

• References

• 1 Ardlie N. G, Glew G, and Schwartz C. J. 1966; Influence of catecholamines on nucleotideinduced platelet aggregation. Nature 212: 415.
• 2 Bergkvist R. 1963; a The proteolytic enzymes of Aspergillus oryzae. I. Methods for the estimation and isolation of the proteolytic enzymes. Acta chemica Scandinavica 17: 1521.
• 3 Bergkvist R. 1963; b The proteolytic enzymes of Aspergillus oryzae. II.Properties of the proteolytic enzymes. Acta chemica Scandinavica 17: 1541.
• 4 Bergkvist R. 1963; c The proteolytic enzymes of Aspergillus oryzae. III. A comparison of the fibrinolytic and fibrinogeno lytic effects of the enzymes. Acta chemica Scandinavica 17: 2230.
• 5 Bergkvist R. 1963; d The proteolytic enzymes of Aspergillus oryzae. IV. On the inhibition of the enzymes by serum. Acta chemica Scandinavica 17: 2239.
• 6 Bergkvist R, and Svärd P. O. 1964; Studies on the thrombolytic activity of a protease from Aspergillus oryzae. Acta physiologica Scandinavica 60: 363.
• 7 Born G. V. R. 1962; Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927.
• 8 Bygdeman S. 1967; Effect of an Aspergillus enzyme on adenosine-diphosphate (ADP) induced platelet aggregation and adhesiveness. Life Science 6: 499.
• 9 DeGaetano G, Vermylen J, and Verstraete M. 1971; L’ inhibition de l’agrégation plaquet-taire: Données expérimentales et perspectives cliniques. Nouvelle Revue Française d’Hématologie 11: 339.
• 10 DeNicola P, Gibelli A, Turazza G, and Giarola P. 1967; Influence of an Aspergillus enzyme on ADP-induced platelet aggregation and fibrinolysis. Life Science 6: 1233.
• 11 Dyer A. E, and Kadar D. 1964; Fibrin suspension assay for fibrinolytic activity. Blood 23: 729.
• 12 Egan E. L. 1969; Local use of protease in haemodialysis clotting problems. Journal of the Irish Medical Association 62: 179.
• 13 Freedman H. J, and Roschlau W. H. E. 1970; Some factors influencing the toxicity of thrombolytic enzymes (Brinase). Canadian Journal of Physiology and Pharmacology 48: 69.
• 14 French J. E. 1966; Atherosclerosis in relation to the structure and function of the arterial intima, with special reference to the endothelium. International Review of Experimental Pathology 5: 253.
• 15 Frisch P, Hedin L, Lund F, and Magnusson G. 1970. Intraarterielle regionale Thrombolyse mit Protease I. Tierexperimentelle Untersuchung über eine mögliche Interferenz mit Röntgenkontrastmittel. In: Marx R, and Thies H. A. (eds.) Thrombose und Embolie. F. K. Schattauer Verlag; Stuttgart-New York.: 231.
• 16 Giering J. E, and Truant A. P. 1966; An experimental method for quantitative evaluation of thrombolysis : Effect of CA-7, a protease from Aspergillus oryzae. Angiology 17: 661.
• 17 Haslam R. J. 1964; Role of adenosine diphosphate in the aggregation of human blood platelets by thrombin and by fatty acids. Nature 202: 765.
• 18 Horace J. F, and Stefanini M. 1959; Fibrinolysis III. Nutritional and environmental requirements for optimum production of fibrinolysin from Aspergillus (Aspergillin 0). Proceedings of the Society for Experimental Biology and Medicine 102: 201
• 19 Hovig T. 1963; Release of platelet-aggregating substance (adenosine diphosphate) from rabbit blood platelets induced by saline “extract” of tendons. Thrombosis et Diathesis Haemorrhagica 9: 264.
• 20 Huang C. L, O’Brien E. T, and Thornes R. D. 1969; The thrombolytic action of Protease I on experimentally produced venous thrombi in the dog. Irish Journal of Medical Science 2: 379.
• 21 Ives D. A. J, and Tosoni A. L. 1967; Purification of CA-7, a thrombolytic fungal protease. Canadian Journal of Biochemistry 45: 1055.
• 22 Jürgens J. 1966 a Experience with the therapeutic use of Protease I and CA 7 in about 50 patients. Personal communication.
• 23 Jürgens J. 1966; b Effect of an Aspergillus enzyme on platelet aggregation in humans. Life Science 5: 1379.
• 24 Jürgens J, Lindvall S, Magnusson O, and Orth K. 1970; Proteolytic inhibitors in plasma from man treated with a protease from Aspergillus oryzae. Acta physiologica Scandinavica 78: 11.
• 25 Kessel M, Bennhold I, and Froese P. 1968; Untersuchungen über die Wirksamkeit eines neuen fibrinolytischen Enzyms zur lokalen Thrombolyse am Scribner-Shunt. Klinische Wochenschrift 46: 1263.
• 26 Kiessling H, and Svenson R. 1970; Influence of an enzyme from Aspergillus oryzae, Protease I, on some components of the fibrinolytic system. Acta chemica Scandinavica 24: 569.
• 27 Kopeć M, Budzyński A, Stachurska J, Wegrzynowicz Z, and Kowalski E. 1966; Studies on the mechanism of interference by fibrinogen degradation products (FDP) with platelet function. Role of fibrinogen in the platelet atmosphere. Thrombosis et Diathesis Haemorrhagica 15: 476.
• 28 Kowalski E, Kopeć M, and Wegrzynowicz Z. 1963; Influence of fibrinogen degradation products (FDP) on platelet aggregation, adhesiveness and viscous metamorphosis. Thrombosis et Diathesis Haemorrhagica 10: 406.
• 29 Larrieu M. J. 1971. Action of fibrinogen degradation products and fibrin monomer soluble complexes on platelet aggregation. In: Verstraete M, Vermyleist J, and Donati M. B. (eds.) Fibrinogen Degradation Products. Munksgaard; Copenhagen: 273.
• 30 Latallo Z. S, Teisseyre E, Wegrzynowicz Z, and Kopeć M. 1971. Degradation of fibrinogen by proteolytic enzymes. In: Verstraete M, Vermylen J, and Donati M. B. (eds.) Fibrinogen Degradation Products. Munksgaard; Copenhagen: 15.
• 31 Lindvall S, Magnusson O, and Orth K. 1969; On the inhibition of a fibrinolytic enzyme from Aspergillus oryzae by serum. Acta chemica Scandinavica 23: 2165.
• 32 Lund F, Hellström L, and Frisch P. 1968; a Combined arteriography and regional thrombolytic therapy. Opuscula medica 13: 281.
• 33 Lund F, Hellström L, and Frisch P. 1968; b Side effects observed in combined arteriography and regional thrombolytic therapy with protease. Opuscula medica 13: 396.
• 34 Monkhouse F. C, Daramola F, and Gillespie R. J. 1964; The action of a proteolytic enzyme from Aspergillus oryzae on components of the blood clotting system. Canadian Journal of Physiology and Pharmacology 42: 377.
• 35 Mustard J. F. 1968; Hemostasis and thrombosis. Seminars in Hematology 5: 91.
• 36 Mustard J. F, and Packham M. A. 1970; Thromboembolism – A manifestation of the response of blood to injury. Circulation 42: 1.
• 37 O’Brien E. T, Thornes R. D, O’Brien D, and Hogan B. 1968; Inhibition of antiplasmin, and fibrinolytic effect of protease in patients with cancer. Lancet 1: 136.
• 38 O’Brien J. R. 1964; Variability in the aggregation of human platelets by adrenaline. Nature 202: 1188.
• 39 Parker J. M, and Boyd J. G. 1968; Safety of CA-7 (fibrinolytic enzyme) for direct pulmonary artery perfusion. International Journal of Clinical Pharmacology I: 545.
• 40 Parker R. C. 1961. Methods of Tissue Culture. 3rd edn.. P. B. Hoeber, Inc.; New York: 53-61.
• 41 Perry A. W. 1968; Treatment of clotting in arterial hemodialysis cannulae with CA-7 (fibrinolytic enzyme derived from Aspergillus oryzae). Canadian Medical Association Journal 98: 762.
• 42 Roschlau W. H. E. 1964; The evaluation in the dog of a proteolytic enzyme derived from Aspergillus oryzae. Canadian Journal of Physiology and Pharmacology 42: 109.
• 43 Roschlau W. H. E. 1965; Natural protease resistance to CA-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Canadian Journal of Physiology and Pharmacology 43: 741.
• 44 Roschlau W. H. E. 1966; Systemic toxicity of CA-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Angiology 17: 882.
• 45 Roschlau W. H. E. 1968; Thrombolytic therapy with CA-7, a fibrinolytic enzyme from Aspergillus oryzae: A report of two representative cases. Canadian Medical Association Journal 98: 757.
• 46 Roschlau W. H. E. 1971. a Brinase (CA-7). A new fibrinolytic agent. In: Losito R, and Longpre B. (eds.) Current Concepts of Coagulation and Hemostasis. F. K. Schattauer Verlag; Stuttgart-New York.: 229.
• 47 Roschlau W. H. E. 1971. b The use of brinase (fibrinolytic enzyme from Aspergillus oryzae) in the management of clotting problems in long-term hemodialysis. In Mammen E. F, Anderson G. F, and Barnhart M. I. (eds.) Thrombolytic Therapy. F. K. Schattauer Verlag; Stuttgart-New York: 217.
• 48 Roschlau W. H. E, and Fisher A. M. 1966; Thrombolytic therapy with local perfusions of CA-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Angiology 17: 670.
• 49 Roschlau W. H. E, Feeedman H. J, and Miller S. L. 1969; Pharmacological modification of the vascular response to systemically administered thrombolytic enzymes (CA-7). Canadian Journal of Physiology and Pharmacology 47: 369.
• 50 Roschlau W. H. E, and Tosoni A. L. 1965; Thrombolytic therapy with CA-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Canadian Journal of Physiology and Pharmacology 43: 731.
• 51 Schmidt H. W. 1965; Thrombolyse durch Plasminogen-Aktivierung und durch direkte Proteolyse. Arzneimittel-Forschung (Drug Research) 15: 132.
• 52 Schmidt H. W. 1966; a Zur Thrombolyse mit verschiedenen Fibrinolytica. I. Untersuchungen an experimentellen menschlichen Nativblutthromben. Klinische Wochenschrift 44: 618.
• 53 Schmidt H. W. 1966; b Zur Thrombolyse mit verschiedenen Fibrinolytika. II. In vitro-Unter-suchungen an intravital entstandenen menschlichen Thromben. Klinische Wochenschrift 44: 621.
• 54 Spaet T. H, and Erichson R. B. 1966; The vascular wall in the pathogenesis of thrombosis. Thrombosis et Diathesis Haemorrhagica, Suppl 21: 67.
• 55 Spaet T. H, and Zucker M. B. 1964; Mechanism of platelet plug formation and role of adenosine diphosphate. American Journal of Physiology 206: 1267.
• 56 Stefanini M, Ad Amis D. M, Soardi F, Marin H. M, and Mele R. H. 1959; Purification of Aspergillin O. Lancet 2: 443.
• 57 Stefanini M, and Marin H. M. 1958; Fibrinolysis. I. Fibrinolytic activity of extracts from nonpathogenic fungi. Proceedings of the Society for Experimental Biology and Medicine 99: 504.
• 58 Svärd P. O. 1966; The effect of an enzyme preparation from Aspergillus oryzae on the aggregation of rabbit platelets in vitro. Scandinavian Journal of Haematology 3: 277.
• 59 Thornes R. D. 1968; Inhibition of antiplasmin, and effect of Protease I in patients with leukaemia. Lancet 2: 1220.
• 60 Tosoni A. L, Glass D. G, Ives D. A. J, Roschlau W. H. E, and Fisher A. M. 1970 Brinase — a blood-clot-lysing enzyme. Joint Conference of the American Chemical Society and the Chemical Institute of Canada, Toronto, Ontario, Canada, 27 May 1970.
• 61 Wallen P. 1971. Plasmic degradation of fibrinogen. In: Verstraete M, Vermylen J, and Donati M. B. (eds.) Fibrinogen Degradation Products. Munksgaard; Copenhagen: 3.